Nuwellis, Inc. (NUWE) stock
NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/3082% below fair value
$5.03−0.50 (-9.04%)
Close on Nov 12, 2026Market cap $2.72MP/E –Yield –
Nuwellis operating margin
Operating margin is operating income as a percentage of revenue.
Nuwellis's operating margin for the twelve months ending Sep 30, 2026 was -135.8%. For fiscal 2025 it was -134.3%, against -125.7% the year before. The highest annual figure on record is -125.7% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -134.3% | −8.6 |
| FY2024 | Dec 31, 2024 | -125.7% | +73.2 |
| FY2023 | Dec 31, 2023 | -198.9% | +2.1 |
| FY2022 | Dec 31, 2022 | -201.0% | +45.5 |
| FY2021 | Dec 31, 2021 | -246.5% | −17.7 |
| FY2020 | Dec 31, 2020 | -228.8% | +99.7 |
| FY2019 | Dec 31, 2019 | -328.5% | +12.3 |
| FY2018 | Dec 31, 2018 | -340.9% | +76.0 |
| FY2017 | Dec 31, 2017 | -416.9% | +798.2 |
| FY2016 | Dec 31, 2016 | -1215.1% | +42781.6 |
| FY2015 | Dec 31, 2015 | -43996.6% | −35255.3 |
| FY2014 | Dec 31, 2014 | -8741.4% | +30023.1 |
| FY2013 | Dec 31, 2013 | -38764.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -92.8% | +28.8 |
| Q2 FY2026 | Jun 30, 2026 | -160.9% | +7.5 |
| Q1 FY2026 | Mar 31, 2026 | -190.1% | −29.4 |
| Q4 FY2025 | Dec 31, 2025 | -100.8% | +2.0 |
| Q3 FY2025 | Sep 30, 2025 | -121.7% | −56.9 |
| Q2 FY2025 | Jun 30, 2025 | -168.5% | −62.7 |
| Q1 FY2025 | Mar 31, 2025 | -160.7% | +95.0 |
| Q4 FY2024 | Dec 31, 2024 | -102.8% | +38.0 |
| Q3 FY2024 | Sep 30, 2024 | -64.7% | +66.5 |
| Q2 FY2024 | Jun 30, 2024 | -105.7% | +136.3 |
| Q1 FY2024 | Mar 31, 2024 | -255.7% | +64.7 |
| Q4 FY2023 | Dec 31, 2023 | -140.8% | +53.0 |
| Q3 FY2023 | Sep 30, 2023 | -131.2% | +58.7 |
| Q2 FY2023 | Jun 30, 2023 | -242.0% | −47.7 |
| Q1 FY2023 | Mar 31, 2023 | -320.4% | −91.1 |
| Q4 FY2022 | Dec 31, 2022 | -193.8% | +69.9 |
| Q3 FY2022 | Sep 30, 2022 | -189.8% | +93.5 |
| Q2 FY2022 | Jun 30, 2022 | -194.4% | −5.9 |
| Q1 FY2022 | Mar 31, 2022 | -229.3% | +42.8 |
| Q4 FY2021 | Dec 31, 2021 | -263.8% | −54.1 |
| Q3 FY2021 | Sep 30, 2021 | -283.4% | −59.8 |
| Q2 FY2021 | Jun 30, 2021 | -188.4% | +22.0 |
| Q1 FY2021 | Mar 31, 2021 | -272.1% | +8.1 |
| Q4 FY2020 | Dec 31, 2020 | -209.6% | +115.6 |
| Q3 FY2020 | Sep 30, 2020 | -223.6% | +136.4 |
| Q2 FY2020 | Jun 30, 2020 | -210.4% | +53.6 |
| Q1 FY2020 | Mar 31, 2020 | -280.2% | +108.7 |
| Q4 FY2019 | Dec 31, 2019 | -325.2% | −41.5 |
| Q3 FY2019 | Sep 30, 2019 | -360.0% | −48.2 |
| Q2 FY2019 | Jun 30, 2019 | -264.0% | +116.2 |
| Q1 FY2019 | Mar 31, 2019 | -388.9% | +31.0 |
| Q4 FY2018 | Dec 31, 2018 | -283.7% | +575.7 |
| Q3 FY2018 | Sep 30, 2018 | -311.8% | −12.6 |
| Q2 FY2018 | Jun 30, 2018 | -380.3% | −91.0 |
| Q1 FY2018 | Mar 31, 2018 | -419.9% | −163.7 |
| Q4 FY2017 | Dec 31, 2017 | -859.4% | −448.9 |
| Q3 FY2017 | Sep 30, 2017 | -299.2% | – |
| Q2 FY2017 | Jun 30, 2017 | -289.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -256.2% | – |
| Q4 FY2016 | Dec 31, 2016 | -410.6% | – |
See a number that looks wrong?